These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36531858)

  • 1. Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines.
    Li J; Wu Y; Xiang J; Wang H; Zhuang Q; Wei T; Cao Z; Gu Q; Liu Z; Peng R
    Chem Eng J; 2023 Jan; 456():140930. PubMed ID: 36531858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
    Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy.
    Xu J; Lv J; Zhuang Q; Yang Z; Cao Z; Xu L; Pei P; Wang C; Wu H; Dong Z; Chao Y; Wang C; Yang K; Peng R; Cheng Y; Liu Z
    Nat Nanotechnol; 2020 Dec; 15(12):1043-1052. PubMed ID: 33139933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
    Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
    Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy.
    Liang Z; Cui X; Yang L; Hu Q; Li D; Zhang X; Han L; Shi S; Shen Y; Zhao W; Ju Q; Deng X; Wu Y; Sheng W
    Int J Pharm; 2021 Oct; 608():121091. PubMed ID: 34555477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination.
    Chen Y; Huang Y; Huang H; Luo Z; Zhang Z; Sun R; Wan Z; Sun J; Lu B; Li S
    Mol Ther Nucleic Acids; 2021 Dec; 26():594-602. PubMed ID: 34703645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy.
    Xu J; Wang H; Xu L; Chao Y; Wang C; Han X; Dong Z; Chang H; Peng R; Cheng Y; Liu Z
    Biomaterials; 2019 Jul; 207():1-9. PubMed ID: 30947117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A General Strategy toward Self-assembled Nanovaccine Based on Cationic Lentinan to Induce Potent Humoral and Cellular Immune Responses.
    Yu R; Jin L; Song Z; Jiao L; Wang Z; Zhou Y; Ma Y; Guan S; Zhang Z; Wang D; Liu H; Sun Y; Zhang S; Cai T; Sun H; Qiu Y; Miao J; Liu Z
    Small; 2024 Oct; 20(43):e2402792. PubMed ID: 38940386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy.
    Zhao H; Xu J; Li Y; Guan X; Han X; Xu Y; Zhou H; Peng R; Wang J; Liu Z
    ACS Nano; 2019 Nov; 13(11):13127-13135. PubMed ID: 31710460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity.
    Xu Y; Ma S; Zhao J; Chen H; Si X; Huang Z; Yu Z; Song W; Tang Z; Chen X
    Biomaterials; 2022 May; 284():121489. PubMed ID: 35364489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 13. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase.
    Guan X; Chen J; Hu Y; Lin L; Sun P; Tian H; Chen X
    Biomaterials; 2018 Jul; 171():198-206. PubMed ID: 29698869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.
    Song C; Noh YW; Lim YT
    Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy.
    Nam J; Son S; Park KS; Moon JJ
    Adv Sci (Weinh); 2021 Mar; 8(5):2002577. PubMed ID: 33717838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.
    Dong H; Wen ZF; Chen L; Zhou N; Liu H; Dong S; Hu HM; Mou Y
    Int J Nanomedicine; 2018; 13():3353-3365. PubMed ID: 29922056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger.
    Hu Y; Lin L; Chen J; Maruyama A; Tian H; Chen X
    Biomaterials; 2020 Sep; 252():120114. PubMed ID: 32422491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Enhanced Antitumor Immunity by a Three-Barreled Strategy of the l-Arginine-Promoted Nanovaccine and Gene-Mediated PD-L1 Blockade.
    Hu Y; Lin L; Chen J; Hao K; Zhang S; Guo X; Guo Z; Tian H; Chen X
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41127-41137. PubMed ID: 32808767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy.
    Sui Y; Li J; Qu J; Fang T; Zhang H; Zhang J; Wang Z; Xia M; Dai Y; Wang D
    Asian J Pharm Sci; 2022 Jul; 17(4):583-595. PubMed ID: 36101894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.